Latest Headlines
-
Cepheid And Oxford Nanopore Technologies Partner To Advance Automated Sequencing-Based Solutions
4/11/2025
Oxford Nanopore Technologies, the company behind a new generation of sequencing-based molecular analysis technologies, and Cepheid, a leading molecular diagnostics company, today announced a strategic collaboration to develop and commercialize a seamless end-to-end workflow that combines Cepheid's GeneXpert system for pre-sequencing sample and library preparation with Oxford Nanopore's rapid, information-rich molecular analysis platform.
-
Bruker Complements Fast, Cost-Effective IR Biotyper Hospital Hygiene Testing And HAI Tracing With NGS Reflex Testing
4/11/2025
At the ESCMID Global 2025 conference, Bruker´s Microbiology and Infection Diagnostics division is announcing the expansion of its microbiology solutions into Next-Generation Sequencing (NGS) applications, with new, research-use only NGS-based solutions in epidemiology and hospital acquired infection (HAI) tracing.
-
Source BioScience Acquires Cambridge Clinical Laboratories
4/10/2025
Source BioScience UK Ltd, an industry-leading provider of genomic services and histopathology diagnostics, today announced it had completed the acquisition of Cambridge Clinical Laboratories (CCL), a leading Cambridge-based provider of clinical, personalised healthcare testing services.
-
Quest Diagnostics Launches New AD-Detect™ Blood Test To Aid In Confirming Alzheimer's Disease
4/9/2025
Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, including advanced diagnostics for brain health, today announced the launch of a new laboratory blood test designed to help physicians confirm amyloid brain pathology due to Alzheimer's disease (AD) in patients with mild cognitive impairment (MCI) or dementia.
-
A New Smartphone-Sized Device Can Test For Tuberculosis. Here's Why That Matters For Children
4/9/2025
Tulane University researchers have developed a first-of-its-kind handheld diagnostic device that can deliver rapid, accurate tuberculosis diagnoses in under an hour, according to a study published in Science Translational Medicine.
-
Seegene Announces Development Of CURECA™, A Next-Generation Fully Automated PCR Solution Featuring Customizable Pre-Treatment Automation
4/9/2025
Seegene Inc., a global leader in molecular diagnostics (MDx), is advancing its vision for innovation in laboratory automation with the development of CURECA™ — a next-generation system currently under development, designed to streamline automation in Polymerase Chain Reaction (PCR) testing and laboratory environments.
-
Vibrant Wellness Advances Hormone Testing With Panel Linking Hormones, Toxins, And Longevity Markers
4/8/2025
Vibrant Wellness, a leading biotech and CAP-accredited lab company, has launched the Hormone Zoomer, an innovative wet urine test that gives integrative medicine professionals a comprehensive view of hormone health, endocrine disruption, and aging-related factors.
-
Scientist.com Launches Clinical Labs Navigator To Expand Clinical Sourcing Capabilities
4/8/2025
Scientist.com, the leading R&D procurement orchestration platform for the life sciences, today announced the launch of Clinical Labs Navigator, a groundbreaking new tool that redefines how clinical trial services are sourced, managed, and executed.
-
Precision For Medicine Partners With SOPHiA GENETICS To Expand Biopharma Services With The SOPHiA DDM™ Platform And Its Liquid Biopsy Capabilities
4/8/2025
Precision for Medicine, a leading provider of drug development and commercialization services, today announced a strategic partnership with SOPHiA GENETICS to enhance its biomarker discovery and precision medicine services.
-
hc1 Unveils Innovative Operational Excellence Healthcare Solutions
4/8/2025
hc1 introduced today its suite of Operational Excellence solutions, setting a new standard for laboratory efficiency and performance.